COVID-19Ministry of Health and Family WelfareHealthIndia

COVID – 19 Vaccination Update – Day 469

India’s cumulative vaccination coverage crosses 188.87 Crore. More than 20 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 188.87 Crore (1,88,87,42,162today. More than 20 lakh (20,30,807) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10405106
2nd Dose 10016402
Precaution Dose 4793359
FLWs 1st Dose 18415663
2nd Dose 17539138
Precaution Dose 7586150
Age Group 12-14 years 1st Dose 28651935
  2nd Dose 6545651
Age Group 15-18 years 1st Dose 58420345
  2nd Dose 42219391
Age Group 18-44 years 1st Dose 555709198
2nd Dose 478049687
Precaution Dose 147257
Age Group 45-59 years 1st Dose 202917430
2nd Dose 187931817
Precaution Dose 517864
Over 60 years 1st Dose 126863397
2nd Dose 117086229
Precaution Dose 14926143
Cumulative 1st dose administered 1001383074
Cumulative 2nd dose administered 859388315
Precaution Dose 27970773
Total 1888742162

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 29th April, 2022 (469th Day)
HCWs 1st Dose 57
2nd Dose 796
Precaution Dose 15939
FLWs 1st Dose 99
2nd Dose 1163
Precaution Dose 40319
Age Group 12-14 years 1st Dose 330196
  2nd Dose 740720
Age Group 15-18 years 1st Dose 46547
  2nd Dose 132028
Age Group 18-44 years 1st Dose 31449
2nd Dose 381652
Precaution Dose 11775
Age Group 45-59 years 1st Dose 4430
2nd Dose 83151
Precaution Dose 34676
Over 60 years 1st Dose 3295
2nd Dose 54749
Precaution Dose 117766
Cumulative 1st dose administered 416073
Cumulative 2nd dose administered 1394259
Precaution Dose 220475
Total 2030807

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button